3172 Federal Register / Vol. 83, No. 15 / Tuesday, January 23, 2018 / Notices 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Announcement of Meeting of the 

Secretary’s Advisory Committee on 

National Health Promotion and Disease 

Prevention Objectives for 2030 

AGENCY: Office of Disease Prevention 

and Health Promotion, Office of the 

Assistant Secretary for Health, Office of 

the Secretary, Department of Health and 

Human Services. 

ACTION: Notice. 

SUMMARY: The U.S. Department of 

Health and Human Services (HHS) 

announces the next meeting of the 

Secretary’s Advisory Committee on 

National Health Promotion and Disease 

Prevention Objectives for 2030 

(Committee) regarding the development 

of national health promotion and 

disease prevention objectives for 2030. 

This meeting will be held online via 

webinar and is open to the public. The 

Committee will discuss the nation’s 

health promotion and disease 

prevention objectives and will provide 

recommendations to improve health 

status and reduce health risks for the 

nation by the year 2030. The Committee 

will develop recommendations 

regarding: Leading Health Indicators; 

the setting of targets for a more focused 

set of measurable, nationally 

representative objectives; the roles of 

health and well-being, health equity, 

and law in Healthy People 2030; and the 

creation of a logic model for 

communicating the role of Healthy 

People 2030, disease prevention, and 

health promotion. Pursuant to the 

Committee’s charter, the Committee’s 

advice must assist the Secretary in 

reducing the number of objectives while 

ensuring that the selection criteria 

identifies the most critical public health 

issues that are high-impact priorities 

supported by current national data. 

DATES: The Committee will meet on 

February 28, 2018, from 2:00 p.m. to 

5:00 p.m. Eastern Time (ET). 

ADDRESSES: The meeting will be held 

online via webinar. To register to attend 

the meeting, please visit the Healthy 

People website at http://

www.healthypeople.gov. 

FOR FURTHER INFORMATION CONTACT: 

Emmeline Ochiai, Designated Federal 

Official, Secretary’s Advisory 

Committee on National Health 

Promotion and Disease Prevention 

Objectives for 2030, U.S. Department of 

Health and Human Services, Office of 

the Assistant Secretary for Health, 

Office of Disease Prevention and Health 

Promotion, 1101 Wootton Parkway, 

Room LL–100, Rockville, MD 20852, 

(240) 453–8280 (telephone), (240) 453– 

8281 (fax). Additional information is 

available on the Healthy People website 

at http://www.healthypeople.gov. 

SUPPLEMENTARY INFORMATION: The 

names and biographies of the 

Committee members are available at 

https://www.healthypeople.gov/2020/ 

about/history-development/healthypeople-2030-advisory-committee. 

Purpose of Meeting: Through the 

Healthy People initiative, HHS leverages 

scientific insights and lessons from the 

past decade, along with new knowledge 

of current data, trends, and innovations, 

to develop the next iteration of national 

health promotion and disease 

prevention objectives. Healthy People 

provides science-based, 10-year national 

objectives for promoting health and 

preventing disease. Since 1979, Healthy 

People has set and monitored national 

health objectives that meet a broad 

range of health needs, encourage 

collaboration across sectors, guide 

individuals toward making informed 

health decisions, and measure the 

impact of our prevention and health 

promotion activities. Healthy People 

2030 health objectives will reflect 

assessments of major risks to health and 

wellness, changing public health 

priorities, and emerging technologies 

related to our nation’s health 

preparedness and prevention. 

Public Participation at Meeting: 

Members of the public are invited to 

join the online Committee meeting. 

There will be no opportunity for oral 

public comments during this online 

Committee meeting. However, written 

comments are welcome throughout the 

entire development process of the 

national health promotion and disease 

prevention objectives for 2030 and may 

be emailed to HP2030@hhs.gov. 

To join the Committee meeting, 

individuals must pre-register at the 

Healthy People website at http://

www.healthypeople.gov. Participation in 

the meeting is limited. Registrations will 

be accepted until maximum webinar 

capacity is reached and must be 

completed by 9:00 a.m. ET on February 

28, 2018. A waiting list will be 

maintained should registrations exceed 

capacity and those individuals will be 

contacted as additional space for the 

meeting becomes available. Registration 

questions may be directed to 

HealthyPeople@norc.org. 

Authority: 42 U.S.C. 300u and 42 U.S.C. 

217a. The Secretary’s Advisory Committee on 

National Health Promotion and Disease 

Prevention Objectives for 2030 is governed 

by provisions of the Federal Advisory 

Committee Act (FACA), Public Law 92–463, 

as amended (5 U.S.C., App.) which sets forth 

standards for the formation and use of federal 

advisory committees. 

Dated: January 17, 2018. 

Don Wright, 

Deputy Assistant Secretary for Health 

(Disease Prevention and Health Promotion). 

[FR Doc. 2018–01143 Filed 1–22–18; 8:45 am] 

BILLING CODE 4150–32–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Meeting of the National Vaccine 

Advisory Committee 

AGENCY: National Vaccine Program 

Office, Office of the Assistant Secretary 

for Health, Office of the Secretary, 

Department of Health and Human 

Services. 

ACTION: Notice. 

SUMMARY: As stipulated by the Federal 

Advisory Committee Act, the 

Department of Health and Human 

Services is hereby giving notice that a 

meeting is scheduled to be held for the 

National Vaccine Advisory Committee 

(NVAC). The meeting will be open to 

the public; public comment sessions 

will be held during the meeting. 

DATES: The meeting will be held on 

February 7 and 8, 2018. The meeting 

times and agenda will be posted on the 

NVAC website at http://www.hhs.gov/ 

nvpo/nvac/meetings/index.html as soon 

as they become available. 

ADDRESSES: U.S. Department of Health 

and Human Services, Hubert H. 

Humphrey Building, Great Hall, 200 

Independence Avenue SW, Washington, 

DC 20201. The meeting can also be 

accessed through a live webcast on both 

days of the meeting. For more 

information, visit http://www.hhs.gov/ 

nvpo/nvac/meetings/index.html. 

Pre-registration is required for 

members of the public who wish to 

attend the meeting and who wish to 

participate in the public comment 

session. Individuals who wish to attend 

the meeting and/or participate in the 

public comment session should register 

at http://www.hhs.gov/nvpo/nvac/ 

meetings/index.html. Participants may 

also register by emailing nvpo@hhs.gov 

or by calling (202) 690–5566 and 

providing their name, organization and 

email address. 

FOR FURTHER INFORMATION CONTACT: 

National Vaccine Program Office, U.S. 

Department of Health and Human 

Services, Room 715H, Hubert H. 

Humphrey Building, 200 Independence 

Avenue SW, Washington, DC 20201. 

Phone: (202) 690–5566; email: nvac@

hhs.gov. 


sradovich on DSK3GMQ082PROD with NOTICES
Federal Register / Vol. 83, No. 15 / Tuesday, January 23, 2018 / Notices 3173 

SUPPLEMENTARY INFORMATION: Pursuant 

to Section 2101 of the Public Health 

Service Act (42 U.S.C. 300aa–1), the 

Secretary of Health and Human Services 

was mandated to establish the National 

Vaccine Program to achieve optimal 

prevention of human infectious diseases 

through immunization and to achieve 

optimal prevention against adverse 

reactions to vaccines. The NVAC was 

established to provide advice and make 

recommendations to the Director of the 

National Vaccine Program on matters 

related to the Program’s responsibilities. 

The Assistant Secretary for Health 

serves as Director of the National 

Vaccine Program. During the February 

2018 NVAC meeting, sessions will 

consist of presentations on vaccine 

innovation, including the current status 

of adjuvants in vaccines, universal 

influenza, and an overview on the 

Secretary of the Department of Health 

and Human Services’ Report to Congress 

on Vaccine Innovation in response to 

the 21st Century Cures Act; a report out 

on the recently approved Presidential 

Advisory Council on Combatting 

Antibiotic-Resistant Bacteria Report, 

‘‘Incentivizing the Development of 

Vaccines, Therapeutics, and Diagnostics 

to Combat Antibiotic Resistant 

Bacteria’’; disparities in adult 

immunizations; and an update on 

strategies to support improving coverage 

for human papillomavirus vaccine. 

Please note that agenda items will be 

related to the charge of the Committee 

and are subject to change as priorities 

dictate. Information on the final meeting 

agenda will be posted prior to the 

meeting on the NVAC website: http://

www.hhs.gov/nvpo/nvac/index.html. 

Public attendance at the meeting is 

limited to the available space. 

Individuals who plan to attend in 

person and need special assistance, 

such as sign language interpretation or 

other reasonable accommodations, 

should notify the National Vaccine 

Program Office at the address/phone 

number listed above at least one week 

prior to the meeting. For those unable to 

attend in person, a live webcast will be 

available. More information on 

registration and accessing the webcast 

can be found at http://www.hhs.gov/ 

nvpo/nvac/meetings/index.html. 

Members of the public will have the 

opportunity to provide comments at the 

NVAC meeting during the public 

comment periods designated on the 

agenda. Public comments made during 

the meeting will be limited to three 

minutes per person to ensure time is 

allotted for all those wishing to speak. 

Individuals are also welcome to submit 

their written comments. Written 

comments should not exceed three 

pages in length. Individuals submitting 

written comments should email their 

comments to the National Vaccine 

Program Office (nvpo@hhs.gov) at least 

five business days prior to the meeting. 

Dated: January 17, 2018. 

Roula Sweis, 

Deputy Director, National Vaccine Program 

Office. 

[FR Doc. 2018–01142 Filed 1–22–18; 8:45 am] 

BILLING CODE 4150–44–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Office of the Secretary; Notice of 

Meeting 

Pursuant to section 10(a) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of 

meetings of the Task Force on Research 

Specific to Pregnant Women and 

Lactating Women. 

The meetings will be open to the 

public, with attendance limited to space 

available. Individuals who plan to 

attend and need special assistance, such 

as sign language interpretation or other 

reasonable accommodations, should 

notify the Contact Person listed below 

in advance of the meeting. 

Name of Committee: Task Force on 

Research Specific to Pregnant Women 

and Lactating Women. 

Date: February 26–27, 2018. 

Time: February 26, 2018, 8:30 a.m. to 

5:00 p.m.; February 27, 2018, 8:00 a.m. 

to 3:00 p.m. 

Agenda: The Task Force is charged 

with providing advice and guidance to 

the Secretary of HHS, regarding Federal 

activities related to identifying and 

addressing gaps in knowledge and 

research regarding safe and effective 

therapies for pregnant women and 

lactating women, including the 

development of such therapies and the 

collaboration on and coordination of 

such activities. 

February 26th, 2018—Day 1 

8:30 a.m.—Welcome and Opening 

Remarks 

8:40 a.m.—Introductions 

8:45 a.m.—Summary and Discussion of 

work products from meetings 1 and 

2 

10:45 a.m.—Follow-up on Task Force 

Request regarding Lessons learned 

from Pediatrics 

1:15 p.m.—Effective communication 

strategies with health care providers 

and the public on information 

relevant to pregnant women and 

lactating women 

1:50 p.m.—Panel: Effective 

communication strategies with 

health care providers on 

information relevant to pregnant 

women and lactating women 

3:30 p.m.—Panel: Effective 

communication strategies with the 

public on information relevant to 

pregnant women and lactating 

women. 

4:10 p.m.—Discussion 

5:00 p.m.—End of Day 1 

February 27th, 2018—Day 2 

8:00 a.m.—Recap from Day 1, Outline & 

Goals of Day 2 

8:15 a.m.—Panel and open discussion to 

cover specific questions on the 

options for a plan or plans to 

identify and address gaps in 

knowledge and research regarding 

safe and effective therapies for 

pregnant women and lactating 

women, including the development 

of such therapies. 

12:45 p.m.—Discussion of Key Points 

related to topic: Effective 

communication strategies with 

health care providers and the 

public on information relevant to 

pregnant women and lactating 

women 

1:30 p.m.—Discussion of Key Points 

related to topic: A plan to identify 

and address gaps in knowledge and 

research regarding safe and 

effective therapies for pregnant 

women and lactating women, 

including the development of such 

therapies 

2:15 p.m.—Review of Recommendations 

from TF1–3 

2:45 p.m.—Action Items, Charge to 

Group 

3:00 p.m.—Adjournment 

Place: 6710B Rockledge Drive, Room 

1425/1427 (1st Floor), Bethesda, MD 

20817. 

Contact Person: Ms. Lisa Kaeser, 

Executive Secretary, Eunice Kennedy 

Shriver National Institute of Child 

Health and Human Development, 31 

Center Drive, Room 2A03, MSC 2425, 

Bethesda, MD 20892, (301) 496–0536, 

kaeserl@mail.nih.gov. 

Public comments are welcome either 

by filing written comments and/or 

providing oral comments at the meeting. 

Oral comments from the public will be 

scheduled on February 26, 2018, from 

approximately 10:00 a.m.–10:45 a.m. 

Any member of the public interested in 

presenting oral comments on February 

26, 2018, should submit a letter of 

intent, a brief description of the 

organization represented, and the oral 

presentation to Ms. Lisa Kaeser 

(Kaeserl@mail.nih.gov) by 5:00 p.m. on 

Monday, February 19, 2018. Written 


sradovich on DSK3GMQ082PROD with NOTICES